Establishment Labs Holdings Inc. (ESTA)

Market Cap	1.65B
Revenue (ttm)	161.70M
Net Income (ttm)	-75.21M
Shares Out	24.42M
EPS (ttm)	-3.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,344
Open	68.47
Previous Close	67.82
Day's Range	67.36 - 68.85
52-Week Range	44.03 - 93.80
Beta	1.03
Analysts	Buy
Price Target	103.02 (+51.52%)
Earnings Date	May 8, 2023

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 746
• Stock Exchange: NASDAQ
• Ticker Symbol: ESTA

Financial Performance

In 2022, ESTA's revenue was $161.70 million, an increase of 27.64% compared to the previous year's $126.68 million. Losses were -$75.21 million, 82.8% more than in 2021.

Analyst Forecast

According to 12 analysts, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $103.02, which is an increase of 51.52% from the latest price.

Price Target

$103.02

(51.52% upside)

Analyst Consensus: Buy